(DHT) DHT Holdings - Ratings and Ratios
Exchange: NYSE •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: MHY2065G1219
Crude Tankers, VLCC, Technical Management
Dividends
| Dividend Yield | 5.80% |
| Yield on Cost 5y | 18.78% |
| Yield CAGR 5y | -7.23% |
| Payout Consistency | 68.6% |
| Payout Ratio | 77.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.5% |
| Value at Risk 5%th | 46.3% |
| Relative Tail Risk | -4.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 28.97 |
| CAGR/Max DD | 0.65 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.548 |
| Beta | 0.388 |
| Beta Downside | 0.666 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.44% |
| Mean DD | 9.93% |
| Median DD | 8.55% |
Description: DHT DHT Holdings November 11, 2025
DHT Holdings Inc. (NYSE:DHT) operates a fleet of 23 very large crude carriers (VLCCs) out of hubs in Monaco, Singapore, Norway, and India, providing crude oil transportation and technical management services. Incorporated in 2005 and headquartered in Hamilton, Bermuda, the company is classified under the Oil & Gas Storage & Transportation sub-industry.
Key metrics: as of Q2 2024 the fleet’s average utilization was ~92%, supporting an EBITDA of roughly $200 million for FY 2024; VLCC spot charter rates have hovered around $30,000-$35,000 per day, reflecting tight supply and strong Asian demand for crude imports. The business is highly sensitive to global oil demand cycles, OPEC production decisions, and the pace of new VLCC deliveries, which together shape freight-rate volatility.
If you want a data-rich, scenario-based assessment of DHT’s valuation, the ValueRay platform offers tools that can help you model those drivers more precisely.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (200.0m TTM) > 0 and > 6% of Revenue (6% = 29.1m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.67% (prev 18.24%; Δ -0.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 269.5m > Net Income 200.0m (YES >=105%, WARN >=100%) |
| Net Debt (187.3m) to EBITDA (325.3m) ratio: 0.58 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (160.7m) change vs 12m ago -0.51% (target <= -2.0% for YES) |
| Gross Margin 37.72% (prev 36.12%; Δ 1.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.81% (prev 39.52%; Δ -5.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.95 (EBITDA TTM 325.3m / Interest Expense TTM 18.3m) >= 6 (WARN >= 3) |
Altman Z'' 0.67
| (A) 0.06 = (Total Current Assets 146.6m - Total Current Liabilities 60.8m) / Total Assets 1.40b |
| (B) -0.10 = Retained Earnings (Balance) -133.1m / Total Assets 1.40b |
| (C) 0.15 = EBIT TTM 218.3m / Avg Total Assets 1.44b |
| (D) -0.42 = Book Value of Equity -128.1m / Total Liabilities 302.4m |
| Total Rating: 0.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.18
| 1. Piotroski 7.0pt |
| 2. FCF Yield 6.35% |
| 3. FCF Margin 31.34% |
| 4. Debt/Equity 0.25 |
| 5. Debt/Ebitda 0.58 |
| 6. ROIC - WACC (= 8.75)% |
| 7. RoE 18.69% |
| 8. Rev. Trend 43.76% |
| 9. EPS Trend 60.10% |
What is the price of DHT shares?
As of December 07, 2025, the stock is trading at USD 12.76 with a total of 1,415,977 shares traded.
Over the past week, the price has changed by -2.07%, over one month by -2.24%, over three months by +3.81% and over the past year by +41.77%.
Over the past week, the price has changed by -2.07%, over one month by -2.24%, over three months by +3.81% and over the past year by +41.77%.
Is DHT a buy, sell or hold?
DHT Holdings has received a consensus analysts rating of 4.83.
Therefore, it is recommended to buy DHT.
- Strong Buy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DHT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.4 | 20.9% |
| Analysts Target Price | 15.4 | 20.9% |
| ValueRay Target Price | 16.5 | 29.5% |
DHT Fundamental Data Overview November 23, 2025
Market Cap USD = 2.21b (2.21b USD * 1.0 USD.USD)
P/E Trailing = 11.0726
P/E Forward = 13.587
P/S = 4.0993
P/B = 2.0151
P/EG = 3.77
Beta = -0.095
Revenue TTM = 485.6m USD
EBIT TTM = 218.3m USD
EBITDA TTM = 325.3m USD
Long Term Debt = 237.0m USD (from longTermDebt, last quarter)
Short Term Debt = 31.6m USD (from shortTermDebt, last quarter)
Debt = 268.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 187.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.40b USD (2.21b + Debt 268.5m - CCE 81.2m)
Interest Coverage Ratio = 11.95 (Ebit TTM 218.3m / Interest Expense TTM 18.3m)
FCF Yield = 6.35% (FCF TTM 152.2m / Enterprise Value 2.40b)
FCF Margin = 31.34% (FCF TTM 152.2m / Revenue TTM 485.6m)
Net Margin = 41.18% (Net Income TTM 200.0m / Revenue TTM 485.6m)
Gross Margin = 37.72% ((Revenue TTM 485.6m - Cost of Revenue TTM 302.5m) / Revenue TTM)
Gross Margin QoQ = 32.51% (prev 36.97%)
Tobins Q-Ratio = 1.71 (Enterprise Value 2.40b / Total Assets 1.40b)
Interest Expense / Debt = 0.96% (Interest Expense 2.59m / Debt 268.5m)
Taxrate = 0.21% (93.0k / 44.9m)
NOPAT = 217.8m (EBIT 218.3m * (1 - 0.21%))
Current Ratio = 2.41 (Total Current Assets 146.6m / Total Current Liabilities 60.8m)
Debt / Equity = 0.25 (Debt 268.5m / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = 0.58 (Net Debt 187.3m / EBITDA 325.3m)
Debt / FCF = 1.23 (Net Debt 187.3m / FCF TTM 152.2m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.30% (Net Income 200.0m / Total Assets 1.40b)
RoE = 18.69% (Net Income TTM 200.0m / Total Stockholder Equity 1.07b)
RoCE = 16.70% (EBIT 218.3m / Capital Employed (Equity 1.07b + L.T.Debt 237.0m))
RoIC = 15.49% (NOPAT 217.8m / Invested Capital 1.41b)
WACC = 6.74% (E(2.21b)/V(2.48b) * Re(7.44%) + D(268.5m)/V(2.48b) * Rd(0.96%) * (1-Tc(0.00)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.15%
[DCF Debug] Terminal Value 80.09% ; FCFE base≈166.9m ; Y1≈190.4m ; Y5≈262.8m
Fair Price DCF = 28.26 (DCF Value 4.54b / Shares Outstanding 160.8m; 5y FCF grow 16.43% → 3.0% )
EPS Correlation: 60.10 | EPS CAGR: 44.08% | SUE: 2.48 | # QB: 1
Revenue Correlation: 43.76 | Revenue CAGR: 6.81% | SUE: 0.49 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.44 | Chg30d=+0.074 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.106 | Revisions Net=+1 | Growth EPS=+56.5% | Growth Revenue=+35.2%
P/E Trailing = 11.0726
P/E Forward = 13.587
P/S = 4.0993
P/B = 2.0151
P/EG = 3.77
Beta = -0.095
Revenue TTM = 485.6m USD
EBIT TTM = 218.3m USD
EBITDA TTM = 325.3m USD
Long Term Debt = 237.0m USD (from longTermDebt, last quarter)
Short Term Debt = 31.6m USD (from shortTermDebt, last quarter)
Debt = 268.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 187.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.40b USD (2.21b + Debt 268.5m - CCE 81.2m)
Interest Coverage Ratio = 11.95 (Ebit TTM 218.3m / Interest Expense TTM 18.3m)
FCF Yield = 6.35% (FCF TTM 152.2m / Enterprise Value 2.40b)
FCF Margin = 31.34% (FCF TTM 152.2m / Revenue TTM 485.6m)
Net Margin = 41.18% (Net Income TTM 200.0m / Revenue TTM 485.6m)
Gross Margin = 37.72% ((Revenue TTM 485.6m - Cost of Revenue TTM 302.5m) / Revenue TTM)
Gross Margin QoQ = 32.51% (prev 36.97%)
Tobins Q-Ratio = 1.71 (Enterprise Value 2.40b / Total Assets 1.40b)
Interest Expense / Debt = 0.96% (Interest Expense 2.59m / Debt 268.5m)
Taxrate = 0.21% (93.0k / 44.9m)
NOPAT = 217.8m (EBIT 218.3m * (1 - 0.21%))
Current Ratio = 2.41 (Total Current Assets 146.6m / Total Current Liabilities 60.8m)
Debt / Equity = 0.25 (Debt 268.5m / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = 0.58 (Net Debt 187.3m / EBITDA 325.3m)
Debt / FCF = 1.23 (Net Debt 187.3m / FCF TTM 152.2m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.30% (Net Income 200.0m / Total Assets 1.40b)
RoE = 18.69% (Net Income TTM 200.0m / Total Stockholder Equity 1.07b)
RoCE = 16.70% (EBIT 218.3m / Capital Employed (Equity 1.07b + L.T.Debt 237.0m))
RoIC = 15.49% (NOPAT 217.8m / Invested Capital 1.41b)
WACC = 6.74% (E(2.21b)/V(2.48b) * Re(7.44%) + D(268.5m)/V(2.48b) * Rd(0.96%) * (1-Tc(0.00)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.15%
[DCF Debug] Terminal Value 80.09% ; FCFE base≈166.9m ; Y1≈190.4m ; Y5≈262.8m
Fair Price DCF = 28.26 (DCF Value 4.54b / Shares Outstanding 160.8m; 5y FCF grow 16.43% → 3.0% )
EPS Correlation: 60.10 | EPS CAGR: 44.08% | SUE: 2.48 | # QB: 1
Revenue Correlation: 43.76 | Revenue CAGR: 6.81% | SUE: 0.49 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.44 | Chg30d=+0.074 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.106 | Revisions Net=+1 | Growth EPS=+56.5% | Growth Revenue=+35.2%
Additional Sources for DHT Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle